Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: The first decade of antiretroviral therapy in Africa | Ford et al. Globalization and Health 2011 7 33 http content 7 1 33 H2 globalization 7 AND HEALTH COMMENTARY Open Access The first decade of antiretroviral therapy in Africa Nathan Ford1 2 Alexandra Calmy3 and Edward J Mills4 Abstract The past decade has seen remarkable progress in increasing access to antiretroviral therapy in resource-limited settings. Early concerns about the cost and complexity of treatment were overcome thanks to the efforts of a global coalition of health providers activists academics and people living with HIV AIDS who argued that every effort must be made to ensure access to essential care when millions of lives depended on it. The high cost of treatment was reduced through advocacy to promote access to generic drugs care provision was simplified through a public health approach to treatment provision the lack of human resources was overcome through task-shifting to support the provision of care by non-physicians and access was expanded through the development of models of care that could work at the primary care level. The challenge for the next decade is to further increase access to treatment and support sustained care for those on treatment while at the same time ensuring that the package of care is continuously improved such that all patients can benefit from the latest improvements in drug development clinical science and public health. Introduction Since 2001 the international effort to scale up antiretroviral therapy ART in the developing world has been one of the most important programmes in global health 1 . Initially there was considerable reluctance to provide ART in developing countries due to concerns that treatment was too expensive too complex and that drug resistance would be promoted by inadequate programmes 2 . In particular it was argued that ART was not cost-effective and that prevention interventions should be prioritized 3 . Despite these concerns treatment programmes began to deliver ART
